Latest Research Report on Real World Evidence Solutions Market with its Key Opportunities and Business Challenges
The Real World Evidence Solutions market is valued at 612.0 million in 2017 and projected to reach USD 1,348.1 million by 2023, at a CAGR of 14.3%.
The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent...
Real World Evidence Solutions Market Size, Industry Analysis and Forecast to 2023
According to the new market research “Real World Evidence Solutions Market by Component (Dataset (Claims, Clinical, Pharmacy, Patient), Services), Therapeutic Area (Oncology, Cardiovascular, Immunology), End User (Pharmaceuticals, Medical Devices, Payers, Providers) – Global Forecast to 2023″, analyzes and studies the major market drivers, restraints/challenges, and opportunities....
Latest Research Report on Real World Evidence Solutions Market Growth, Industry Revenue Analysis
The growth of this market
is majorly driven by the rising geriatric population (and the subsequent
increase in the prevalence of chronic diseases), shift from volume- to
value-based care, and delays in drug development (and the subsequent increase
in development costs).
The Real
World Evidence Solutions market is valued at 612.0 million in 2017 and projected to
reach USD 1,348.1 million...
Global Real World Evidence Solutions Market | Top Key Players are Optum, Cognizant, Oracle, SAS, Syneos Health, Anthem, Clinigen Group, Palantir Technologies, and Flatiron Health
The growth of this market is majorly driven by the rising geriatric population (and the subsequent increase in the prevalence of chronic diseases), shift from volume- to value-based care, and delays in drug development (and the subsequent increase in development costs).
The global real world evidence solutions market is projected to reach USD 1,348.1 million by 2023 from USD 689.9 million...